Swedish Neuroscience Institute

Seattle, Washington 98122-4470

2 studies enrolling now · 43 studies all time

What they study most

ALS, Adhesions, Amyotrophic Lateral Sclerosis, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Aneurysm, Intracranial, Astrocytoma, Autoimmune Diseases of the Nervous System, Back Pain, Brain Atrophy, Brain Cancer

Studies at this site

• Deep Brain Stimulation (DBS) Retrospective Outcomes Study — Recruiting now
• RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain — Recruiting now
• Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial) — Recruiting now
• A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity. — Completed
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab — Running, not enrolling
• US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair — Running, not enrolling
• A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis — Completed
• A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis — Completed
• Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders: — Running, not enrolling
• A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients — Completed
• Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment — Running, not enrolling
• Deep Brain Stimulation for Major Depressive Disorder — Stopped early
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease — Completed
• An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) — Completed
• Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma — Paused
• Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM) — Completed
• An Efficacy and Safety Study of Ravulizumab in ALS Participants — Stopped early
• An Intermediate Size Expanded Access Protocol of AMX0035 for ALS — APPROVED_FOR_MARKETING
• Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS — Completed
• Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System — Completed
• Spinal Cord Stimulation With Precision® System Versus Reoperation for Failed Back Surgery Syndrome — Stopped early
• Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis — Completed
• Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed
• A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511 — Stopped early
• Transsphenoidal Extent of Resection Study — Completed
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
• A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study) — Stopped early
• An Adult Spasticity Registry of OnabotulinumtoxinA Treatment — Completed
• Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor — Completed
• A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors — Completed
• Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy — Stopped early
• Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma — Completed
• Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase — Completed
• DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery — Stopped early
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed
• Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) — Completed
• Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis — Completed
• Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS — Withdrawn before enrolling
• Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 — Available (expanded access)
• Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis — Completed
• Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program — Completed